• Integrating Artificial Intelligence and RNA therapeutics to unlock previously inaccessible cures for hundreds of diseases caused by splicing errors.

  • Cancer and genetic diseases

    affect more than 30 million people a year

    Our mission is to reduce the complexity of biomedical data to accelerate the development of innovative therapeutic solutions through RNA splicing analytics and artificial intelligence.

    15%

    of all disease causing mutations are predicted to disrupt RNA splicing

    370

    known genetic disorders in publications are caused by RNA splicing errors

    50%

    of synonymous cancer-driver mutations impair RNA splicing

  • SpliceCore

    Artificial Intelligence Platform for Drug Discovery

  • Investors

    Third Kind Venture Capital
    Dolby Family Ventures
    Empire State Development
    Accelerate Long Island
    Dynamk Capital
    SBIR
    Topspin
    Breakout Labs
    National Institutes of Health
    SV Angel
  • Partners

    Amazon Web Services
    Google Cloud Platform
    Microsoft
  • @envisagenics